The US DoJ announces the launch of a joint initiative to deter, detect and prosecute collusive schemes related to the (...) New Free 22 September 2023 US Department of Justice Antitrust Division US Department of Justice (Washington) United States 176 contributions 74632 visits
The UK Competition Authority publishes its initial report on the regulation of AI New Free 18 September 2023 Christopher Peacock Hogan Lovells (London) United Kingdom 7 contributions 2954 visits , Dan Whitehead Hogan Lovells (London) United Kingdom 1 contribution 270 visits , Angus Coulter Hogan Lovells (London) United Kingdom 8 contributions 1183 visits …
Getting over market definition: The NVIDIA/Arm merger September 2023 Thomas Bowman Compass Lexecon (London) United Kingdom 1 contribution 1154 visits , Thibaut de Bernard Compass Lexecon (Paris) France 1 contribution 1154 visits , Guillaume Duquesne Compass Lexecon (Paris) France 3 contributions 2555 visits
Patent hold-up and the pharmaceutical sector September 2023 Walid Chaiehloudj University of Perpignan France 38 contributions 30504 visits , Marion Provost Dechert (Paris) France 20 contributions 21935 visits , Mélanie Thill-Tayara Dechert (Paris) France 47 contributions 68720 visits …
27 Sep 2023 The EU General Court annuls the Commission’s decision declaring the Spanish tax scheme on the deduction for indirect (...) General Court of the European Union
16 Sep 2023 The US DoJ continues to ramp up enforcement against interlocking directorates in its latest move forcing two (...) Brian Burke, John Fedele, Mark Hamer, Teisha Johnson, Nandu Machiraju, Creighton Macy, Courtney DeVore, Daniel Graulich
15 Sep 2023 The South African Competition Authority publishes new rules that will govern the way online platforms distribute media (...) Competition Commission of South Africa
15 Sep 2023 The South African Competition Authority initiates an investigation into one of the world’s largest pharmaceutical firms (...) Competition Commission of South Africa
14 Sep 2023 The US FTC issues a policy statement warning pharmaceuticals off improperly listing their drugs on the FDA’s "Orange (...) Julia Chapman, George Gordon, Katherine A. Helm, Robert Rhoad, Andrew Figueiredo
Sep 2023 Statement of Concerns regarding the jurisdictional issues arising in the European Commission’s position in relation to (...) Calvin Goldman, Frank Montag, John Pecman
Sep 2023 The economics of new product launches and access to pharmaceutical products in the EU: A perspective on the EC’s (...) Margaret Kyle, Sinan Corus, Julia Tanndal
Sep 2023 Damien Gerard (Belgian Competition Authority): For a rigorous and effective competition policy anchored in market realities Damien Gerard, Isabel Rooms
Sep 2023 Are excessive pricing cases few and far between? A quantitative analysis of fifty years of European jurisprudence 1971–2021 Behrang Kianzad
Sep 2023 UK: Analysing Digital Markets, Competition and Consumers Bill through the prism of the DMA Oles Andriychuk
